Zura Bio (ZURA) Other Non-Current Liabilities (2021 - 2024)

Zura Bio's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $2.4 million for Q2 2024.

• On a quarterly basis, Other Non-Current Liabilities rose 14.26% year-over-year to $2.4 million in Q2 2024; TTM through Jun 2024 was $2.4 million, a 14.26% increase from a year earlier, with the FY2023 full-year figure at $990000.0, down 90.47% from the prior year.
• Other Non-Current Liabilities climbed to $2.4 million in Q2 2024 per ZURA's latest filing, from $1.6 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $10.4 million in Q4 2022 and bottomed at $990000.0 in Q4 2023.
• The 4-year median for Other Non-Current Liabilities is $2.2 million (2023), against an average of $3.5 million.
• Across the five-year window, Other Non-Current Liabilities soared 71.17% in 2022 and sank 90.47% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $6.1 million in 2021, then surged by 71.17% to $10.4 million in 2022, then sank by 90.47% to $990000.0 in 2023, then surged by 138.79% to $2.4 million in 2024.
• Per Business Quant, the three latest ZURA Other Non-Current Liabilities figures stand at $2.4 million (Q2 2024), $1.6 million (Q1 2024), and $990000.0 (Q4 2023).